Do Not Build a Retirement Portfolio in 2026 Without at Least One of These 3 Dividend Kings

Dividend King stocks have become a necessity for all portfolios, including growth-focused ones. PepsiCo (NASDAQ:PEP | PEP Price Prediction), Federal Realty Investment Trust (NYSE:FRT), and Kimberly-Clark (NASDAQ:KMB) are now a must-have for retirement portfolios in particular.

The reason is straightforward. Too many retirement investors have gone deep into covered-call ETFs that track tech stocks, leaving their portfolios without meaningful ballast. Even if your tech exposure is modest, having a set of stocks quietly compounding in the background, without significant cyclicality, can do a lot for long-term outcomes.

There is also a valuation angle. These stocks have been sitting at discounts ever since record interest rate hikes made Dividend Kings look pedestrian next to Treasuries. Now that bond yields have moderated and inflation risk has resurfaced, the market is hungry again for stocks that offer both capital appreciation potential and a durable income stream. The three names below deliver on both counts.

PepsiCo (PEP)

PepsiCo has frustrated Dividend King investors for a few years running, but the case for a rebound is getting harder to ignore. GLP-1 fears appear to have been an overreaction: the stock is finally showing signs of recovery, and while weight-loss drug adoption did slow snack category momentum, revenues have kept growing.

The business trajectory tells the story. PepsiCo posted $67.2 billion in revenue in 2019 alongside $7.3 billion in net income. By 2025, revenue had reached nearly $94 billion and net income had climbed to $8.24 billion, with EBITDA at $15.54 billion. The stock price, however, is barely above where it stood in 2019, which is the opportunity. Management affirmed its 2026 financial outlook and announced a new $10 billion share repurchase program, signaling confidence in the balance sheet.

The business has normalized after the post-COVID demand surge of 2021, when analysts priced in too much permanent growth. The subsequent selloff has pushed PEP to around 18 times forward earnings, a modest multiple for a franchise of this quality. PepsiCo has now raised its dividend for 54 consecutive years, including a 4% annualized increase announced in early 2026, bringing the per-share dividend to $5.92.

Federal Realty Investment Trust (FRT)

Federal Realty is a REIT focused on shopping centers and mixed-use properties in affluent, supply-constrained suburban corridors where shopping, dining, entertainment, office space, and residential living converge. The portfolio is unglamorous in the best possible way: durable, well-leased, and concentrated in markets where new supply is nearly impossible to build.

The trust holds the longest dividend growth streak in the entire REIT industry, now extended to 59 consecutive years after a 3% quarterly dividend increase in mid-2026. Federal Realty has been a steady rather than spectacular performer relative to the broader market, which is precisely what a retirement portfolio needs right now. Interest rate hikes over the past few years weighed on its valuation, but operating momentum has been strong. In Q2 2026, the company signed a record 124 retail leases covering more than 819,000 square feet at 15% cash rent growth, and management raised full-year 2026 Core FFO guidance to a range of $7.48 to $7.56 per diluted share.

CEO Don Wood has noted that the company operates in “a relatively stable interest rate environment that could result in lower rates as the year progresses.” The stock is unlikely to reclaim $150 quickly, but if rate cuts materialize in the back half of 2026, a move toward $120 to $130 is achievable. If they do not, the dividend yield remains a compelling reason to hold and collect.

Kimberly-Clark (KMB)

Kimberly-Clark spent roughly a decade trading sideways before pulling back sharply following its announcement of a major acquisition. The company agreed in November 2025 to acquire Kenvue (NYSE:KVUE) in a cash-and-stock deal valued at approximately $48.7 billion in enterprise value. Shareholders of both companies voted overwhelmingly to approve the transaction in January 2026, U.S. antitrust clearance was secured in February, and the deal is now expected to close by the end of Q4 2026, pending remaining foreign regulatory approvals.

Kimberly-Clark’s management is not acquiring blindly. CEO Mike Hsu sees the combination as a path to higher-growth, higher-margin categories in health and wellness. Bringing brands like Tylenol, Band-Aid, Listerine, Aveeno, and Neutrogena together with Kimberly-Clark’s own household brands creates a portfolio with roughly $32 billion in annual revenue and $7 billion in adjusted EBITDA before synergies. The total anticipated run-rate synergies are projected at $2.1 billion. Upon closing, current Kimberly-Clark shareholders are expected to own approximately 54% of the combined company, with Kenvue shareholders holding the remaining 46%.

On the valuation side, the combined enterprise value is unlikely to exceed $90 billion post-merger, which implies a purchase price of around 13 times EV-to-EBITDA even before synergies are realized. KMB stock itself already trades near that range. For a Dividend King that continues to generate reliable cash flow through the deal process, the current setup looks attractive regardless of exactly when the transaction closes.

Editor’s note: This article has been updated to reflect that PepsiCo has raised its dividend for 54 consecutive years (not 53), that Federal Realty Investment Trust has extended its dividend growth streak to 59 consecutive years after a mid-2026 increase, and that the Kimberly-Clark acquisition of Kenvue cleared shareholder votes in January 2026 and U.S. antitrust review in February 2026, with closing now expected in Q4 2026.

Contact [email protected] for any questions or corrections.